Literature DB >> 9111271

Severe reactions associated with transfusion of patients with sickle cell disease.

G Garratty.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9111271     DOI： 10.1046/j.1537-2995.1997.37497265334.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  13 in total

1.  Red Blood Cell Alloimmunization in Multitransfused Pediatric Population in a Tertiary Care Hospital.

Authors:  A P Poornima; Shiffi Fazal; P S Shaiji; K C Usha; Lalitha Kailas
Journal:  Indian J Pediatr       Date:  2018-12-04       Impact factor: 1.967

2.  Alloimmunization against RBC or PLT antigens is independent of TRIM21 expression in a murine model.

Authors:  Seema R Patel; Jeanne E Hendrickson; Nicole H Smith; Chantel M Cadwell; Keiko Ozato; Herbert C Morse; Ryusuke Yoshimi; James C Zimring
Journal:  Mol Immunol       Date:  2011-01-26       Impact factor: 4.407

3.  Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.

Authors:  Scott T Miller; Hae-Young Kim; Debra L Weiner; Carrie G Wager; Dianne Gallagher; Lori A Styles; Carlton D Dampier; Susan D Roseff
Journal:  Transfusion       Date:  2012-07-13       Impact factor: 3.157

4.  Current problems and future directions of transfusion-induced alloimmunization: summary of an NHLBI working group.

Authors:  James C Zimring; Lis Welniak; John W Semple; Paul M Ness; Sherrill J Slichter; Steven L Spitalnik
Journal:  Transfusion       Date:  2011-01-20       Impact factor: 3.157

Review 5.  Delayed hemolytic transfusion reaction in sickle cell disease.

Authors:  Leslie P Scheunemann; Kenneth I Ataga
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

6.  Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease.

Authors:  Marion E Reid; Christine Halter Hipsky; Kim Hue-Roye; Carolyn Hoppe
Journal:  Blood Cells Mol Dis       Date:  2013-12-02       Impact factor: 3.039

7.  A nontransfusional perioperative management regimen for patients with sickle cell disease undergoing laparoscopic cholecystectomy.

Authors:  D R Leff; T Kaura; T Agarwal; S C Davies; J Howard; A C Chang
Journal:  Surg Endosc       Date:  2006-12-16       Impact factor: 3.453

8.  Blood transfusion in patients with sickle cell disease requiring laparoscopic cholecystectomy.

Authors:  Amr Mostafa Aziz; Abdul-Wahed N Meshikhes
Journal:  JSLS       Date:  2011 Oct-Dec       Impact factor: 2.172

9.  Hyperhemolysis in a patient with beta-thalassemia major.

Authors:  Lakmali R Morawakage; B J C Perera; P D N Dias; S K Wijewardana
Journal:  Asian J Transfus Sci       Date:  2009-01

10.  Post-transfusion hyperhemolysis syndrome in a patient with beta thalassemia major.

Authors:  Ganesh Kasinathan; Jameela Sathar
Journal:  Clin Case Rep       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.